|
Volumn 49, Issue 4, 2001, Pages 1119-1125
|
Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival
|
Author keywords
Chemotherapy; Human tumor xenograft; Hyperthermia; Radiotherapy; Tumor oxygenation
|
Indexed keywords
CISPLATIN;
IFOSFAMIDE;
ANIMAL MODEL;
ARTICLE;
CANCER THERAPY;
CHEMOTHERAPY;
CONTROLLED STUDY;
DISEASE CONTROL;
FEMALE;
HEAD AND NECK CARCINOMA;
HUMAN;
HUMAN TISSUE;
HYPERTHERMIC THERAPY;
MOUSE;
MULTIMODALITY CANCER THERAPY;
NONHUMAN;
OXYGEN TENSION;
PRIORITY JOURNAL;
PROGNOSIS;
RADIOTHERAPY;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
TISSUE OXYGENATION;
TREATMENT OUTCOME;
TUMOR VOLUME;
XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FEMALE;
HEAD AND NECK NEOPLASMS;
HUMANS;
HYPERTHERMIA, INDUCED;
IFOSFAMIDE;
MICE;
MICE, NUDE;
OXYGEN;
PROGNOSIS;
TIME FACTORS;
TRANSPLANTATION, HETEROLOGOUS;
|
EID: 0035869724
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/S0360-3016(00)01523-6 Document Type: Article |
Times cited : (36)
|
References (45)
|